RxDoctor Payments Data

Andrew Russeau, MD

Vascular Surgery · Chicago, ILNPI 1043637150

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (38.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Stryker at 38.4% of the total. 2025 is the largest year on record at $13,636, more than ten times the $196 reported in 2019.

$22,607in general payments, 2019–2025

Across 111 payments — averaging $203.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$9K
  • Bard Peripheral Vascular, Inc.$4K
  • Penumbra, Inc.$3K
  • Abbott$3K
  • Lemaitre Vascular, Inc.$1K
  • Inari Medical, Inc.$698
  • plus $3K from 18 others

What the payments were for

  • Consulting fees$8,80039%
  • Speaking & faculty fees$1,5007%
  • Travel & lodging$4,88722%
  • Food & beverage$7,13932%
  • Education$2811%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,607 in reported general payments places this provider in the 80th percentile of 170 vascular surgery providers in Illinois.

See all vascular surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$214,715
Medicare patients
1,541
Services billed
2,986

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$15,576
Gabapentin12$222
Atorvastatin Calcium12$117
ClopidogrelClopidogrel Bisulfate12$84
Tramadol Hcl11$16

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →